Running title: Overlap Resolved CEST (orCEST) MRI reveals GABA and Glutamate in-vivo
Introduction
Molecular Imaging aims at spatially resolving signals originated from specific molecules with high precision and, preferably, noninvasively. Chemical Exchange Saturation Transfer (CEST) is a Magnetic Resonance Imaging (MRI) modality offering Molecular Imaging capabilities for contrasting endogenous metabolites: rather than using a genetically-labelled fluorophore or radioactive tracer, CEST MRI simply harnesses saturation ( Fig. 1A) (or, less commonly, inversion or phase) transfer of signals originating from particular molecular species to the ubiquitous water signals 1, 2 ,which can then be imaged at a high spatial resolution and completely noninvasively. For example, CEST MRI has been used to detail Glycogen variations in the liver 3 ; report on glucose uptake and metabolism 4 , detect myoinositol differences in grey/white matter 5 ; and delineate creatine in skeletal muscle 6 . Also, CEST MRI was reported to be capable of mapping pH changes in the brain, and was used in many other applications [7] [8] [9] .
Despite that specificity is the main goal of Molecular Imaging in general and CEST experiments in particular, CEST's specificity can suffer from spectral overlap of different chemical moieties ( Fig.   1B ). That is, two different molecules may have overlapping spectra which, upon saturation, provide partial contributions from both resonances rather than the desired one. In addition resonances from the same proton can have different offsets due to pH 10 . A striking example for spectral overlap between different molecules involves exchangeable protons of Glutamate (Glu) and Gammaaminobutyric acid (GABA), the Central Nervous System's primary excitatory and inhibitory neurotransmitters, respectively 11 . Glutamate and GABA's roles in neural activity are paramount not only in normal brain function, but also in many brain disorders, including, among others, dementia, depression, epilepsy and schizophrenia [12] [13] [14] [15] [16] . Changes in Glu and GABA concentrations have been spectroscopically detected in a single voxel in disease 14 , development 17 , and plasticity 18 , both in humans 19 and in rodents 13 . CEST MRI targeting Glutamate signals (termed GluCEST) has been recently reported 10 . However, Glutamate and GABA have very similar chemical compositions, and both exhibit CEST effects for their respective amine moieties. Contamination from other metabolites, including GABA, has been largely discounted in previous gluCEST literature 10, [20] [21] [22] , discarded as minimal due to (assumingly) sufficient spectral separation between the metabolite resonances; low competing CEST effect due to specific metabolite exchange rates; or even simply due to GABA's lower relative concentration in the brain 23 . Still, this ambiguity can have significant consequences in the interpretation of gluCEST data, due to the opposing neurotransmission effects. GABA CEST 24, 25 has rarely been claimed compared to its Glutamate counterpart, likely due to the same overlap issue.
Here, we propose a general methodology capable of resolving spectral overlaps in CEST, termed overlap-resolved CEST (orCEST), which serves to significantly enhance CEST specificity. We investigate the extent of contamination between Glu and GABA in conventional gluCEST, and then demonstrate that, using the novel orCEST approach, both metabolites can be fully resolved and mapped separately. The first in-vivo orCEST experiments resolving Glu and GABA in-vivo are reported; changes in Glu and GABA levels, likely reflecting Glutamatergic and GABAergic mechanisms, are observed upon water-deprivation in the rat, in specific brain areas regulating thirst [26] [27] [28] [29] [30] [31] [32] . Potential implications for future studies are discussed.
Results orCEST principles and optimisiation
Conventional CEST irradiation is typically performed at a particular frequency, (Figure 1 ), aiming to maximize the contrast; however, contaminations from all the underlying signals are then also present. Chemical exchange transfers magnetization to bulk water, resulting in indirect saturation of the bulk water that is dependent on the frequency of irradiation. (B) orCEST method for resolving metabolite overlap, detailing the necessary steps and conditions to increase specificity in targeting a given metabolite i by reducing metabolite's j contribution to the total CESTasym signal (C) CEST asymmetry curves for Glutamate and GABA at pH 7.2, with vertical grey lines depicting the acquisition frequencies necessary for orCEST calculation and blue and red horizontal lines displaying frequencies where ωa = ωb for Glutamate and GABA, respectively. (D) Comparison between Conventional CEST and orCEST Glutamate (10 mM) and GABA (2 mM) at pH 7.2, showing increased specificity in orCEST.
As explained above, the main goal of orCEST is to enhance the specificity of CEST experiments. The idea behind orCEST is in fact very simple, and is an analogue of spectral editing typically used in NMR 33 , but applied to the CEST asymmetry (CESTasym) spectra ( Fig. 1B ). If two metabolite signals partially overlap, their CESTasym spectra will display partially shifted peaks ( Fig. 1B) ; if the z-spectra are a-priori known (i.e., measured in phantoms for example), symmetric points can be chosen around the peak and subtracted. Upon such subtraction, the contamination arising from the complementary molecules is effectively subtracted and cancelled out. In the orCEST experiment, maps are generated by subtracting images saturated at at − and + , normalized to M0. Thus, in orCEST, a total of four images are required, each acquired at different saturation frequencies (as well as another M0 image). In the case of Glu and GABA, the resonances to be saturated were chosen as ±1.15/±0.35 p.p.m., and ±0.75/±2.15 p.p.m., for resolving Glutamate and GABA, respectively ( Fig. 1c ).
For optimisation purposes, a range of saturation parameters were investigated, varying in number, length, power, duration, and separation of saturation pulses. From this initial screening, a subset of parameters suitable for orCEST saturation was chosen, and consisted of a train of 22 Gaussian pulses, 182 ms in duration and 15 Hz in width, and applied with 10 µT amplitudes and an inter-pulse delay of 5 ms. For other experimental details, the reader is referred to the Methods section.
orCEST enhances specificity for Glu and GABA
To investigate how orCEST could enhance the spectral specificity, we first show how different metabolites contribute to conventional CEST contrast (particularly, to gluCEST). Fig. 2A shows the experimental setup, incorporating different metabolites at physiological concentration (detailed in caption); Figure 2B shows the corresponding CESTasym curves for these metabolites, while Fig metabolites (Glu 20%, NAA 3%, GABA 7%, MI 1%, Cr 4%, Gln 7%), and, more importantly, with a considerable amount emerging from GABA -arguably the least desired contribution due to its opposing action to Glu in neurotransmission. By contrast, when the orCEST methodology is used, the specificity is significantly enhanced and the contrast reflects mainly Glutamate, containing only smaller residual signals from other molecules (Glu 16%, NAA 0.5%, GABA 2%, MI 3%, Cr 2%, Gln 1%).
Notice that other molecules are nearly in the noise level due to orCEST subtraction. Most importantly, GABA's contribution to Glutamate orCEST is now greatly reduced. As mentioned earlier, conventional gabaCEST contrast has insofar not been widely reported 24, 25 as its glutamate counterpart. Fig. 2E displays the conventional gabaCEST contrast and its orCEST counterpart, showing the likely reason: conventional gabaCEST is severely contaminated with Glutamate and other molecules and in fact, the Glutamate signal is stronger than GABA's (Glu 16%, NAA 2%, GABA 15%, MI 2%, Cr 8%, Gln 9%). Indeed, GABA only contributes to about a quarter of total signal in a conventional gabaCEST acquisition ( Fig. 2F ), suggesting that indeed it would be difficult to ascribe specificity to gabaCEST under these conditions. When orCEST was attempted to resolve GABA, specificity was greatly enhanced in orCEST contrast. Residual contributions from Glutamate, Glutamine and Creatine are minor, with a special interest for the reduction on Glutamate contribution (Glu 2.5%, NAA 0.5%, GABA 14%, MI 1.5%, Cr 1.5%, Gln 2.5%).
It is worth noting that the subtraction inherent to orCEST incurs a small loss in sensitivity, which was found to be around 10-20%.
Glutamate and GABA CEST -pH effects
In the CNS, Glutamate and GABA are compartmentalized into at least two distinct main pools: extravesicular (mainly in the synaptic cleft and the cytosol) and intra-vesicular (within synaptic vesicles).
Interestingly, each of these spaces is characterized by a very different pH: ~7.2 and ~5.5 for synaptic and intravesicular, respectively 34 . Conventional gluCEST is thought to originate mainly from pH 5.5 10 ;
however, given the strong effects shown above, it could be suspected that different pH environments may significantly contribute to CEST contrast. The map corresponding to conventional gluCEST, which primarily targets Glutamate at pH 5.5
is shown in Fig. 3C with orCEST, it again is able to distinguish between the populations, as evident from the lack of signal in the Glutamate tubes. Furthermore, we were able to isolate the GABA residing at pH 7.2, with very little GABA at pH 5.5 residuals (Glu pH7.2 2.5%, Glu pH5.5 2.5%, GABA pH7.2 8%, GABA pH5.5 1%), as seen in Fig. 3F .
In vivo orCEST. Following orCEST validation in-vitro, the first experiments in-vivo were performed in rats. Figure 4A shows the raw data from such acquisitions at three different saturation frequencies (0,-3 and +3 p.p.m.), showing the effects of direct saturation and asymmetry in saturation. In-vivo orCEST maps of Glutamate and GABA (pH 7.2) are shown in Fig. 4B and C, respectively.
Lower levels of Glutamate and GABA were found in areas rich in white matter. Glutamate levels were ~4 times higher than GABA, as expected for standard physiological levels in the brain 13, 19, 35, 36 . . (B,C) orCEST contrast for Glutamate and GABA in the rat brain, acquired across an axial plane at bregma 0.7/-0.9 /-1.46mm.
Application of orCEST in water deprivation. Thirst regulation involves several brain regions
and Glutamatergic/GABAergic mechanisms. Imaging those noninvasively could make a big impact on understanding brain circuitry in-vivo. Here, orCEST was used to investigate changes in these neurotransmitters in the rat brain in vivo upon water deprivation.
A general decreasing trend is shown for both GABA and Glutamate orCEST in a ROI encompassing the whole brain (see Fig. 5A ). However, specific structures, such as the Hypothalamus (Fig. 5B ), Corpus Callosum (Fig. 5C ) and Caudate Putamen (Fig.5D ), exhibited a different behaviour upon water deprivation, with Glutamate evidencing a significant decrease for the 24H group, followed by an increase in the for the 36H group. This suggests that specific structures may have some sort of compensatory mechanism for Glutamate and GABA that is implicated in thirst regulation. Figure 5 . orCEST variations upon water deprivation in rats at 9.4T (A) Analysis on the average of all structures shows a significant downwards trend in both Glutamate and GABA between Control, 24H and 36H groups. This is the case for most brain structures. (B,C,D) Specific structures, such as the Hypothalamus (bregma -1,46mm), Corpus Callosum (bregma -0.9mm) and Caudate Putamen (bregma -0.9mm), exhibit a different behaviour upon water deprivation.
Discussion
CEST experiments in general, and Glu/GABA-CEST in particular, strive to enhance the specificity of MRI experiments. However, CEST-based contrasts typically saturate at the resonance peaks to maximize contrast; in such settings, the specificity of the methodology may be significantly reduced, as here shown, due to spectral overlap from other metabolites. Many parameters can be expected to affect the degree of contamination by unwanted metabolites, including the respective frequencies and magnetic fields, as well as exchange rates, pH, and temperature. Still, it seems that, especially for Glutamate and GABA, conditions are unfavourable for conventional CEST experiments.
We presented the orCEST methodology, which aims at enhancing the specificity, even if at the expense of scan time (orCEST requires double the images, but if the resonances are judiciously chosen, orCEST will also report on double the metabolites) and some small decrease in sensitivity due to saturation off-peak. However, we have shown that orCEST provides significantly enhanced specificity which potentially resolves the molecular overlap and can partially resolve pH-related overlap, thereby providing exciting vistas for future mapping of specific (sub)cellular environments in-vivo.
Our findings are important in the context of interpretation of CEST contrasts in general, and
GluCEST in particular. Indeed, GluCEST contrasts in different conditions, such as stroke models, epilepsy, psychosis or Huntington's disease 10,21,22,37 have shown markedly different contrasts. Given the GABA contributions to GluCEST here shown, one must consider whether GABAergic contributions could have played an important role in these contrasts.
As a general method for measuring long term Glutamate/GABA changes in the brain, orCEST may prove to be quite a valuable tool due to its increased specificity, especially for GABA measurements in vivo. GABA also plays a very important role in disease [38] [39] [40] , and studying its variation may become a possible with orCEST. Epileptic drugs for example, often rely on the inhibition of release/reuptake of GABA in gabaergic neurons 41 , and less so on Glutamatergic processes. orCEST could provide specificity and thereby facilitate direct imaging of such effects. Indeed, in our water deprivation model, with the exception of three major structures, Hypothalamus (bregma -1,46mm), Corpus Callosum (bregma -0.9mm), and Caudate Putamen (bregma -0.9mm) (supplementary Fig. 1 ), most brain regions show a consistent decrease in both Glutamate and GABA orCEST. Previous studies on rat models have reported an increase in hypothalamic Glutamate, upon acute dehydration over a 48h period 42 , and for both Glutamate and GABA upon 7 to 10 days of chronic dehydration (2% NaCl in water) 43 , evidenced by an increase in the frequency of spontaneous excitatory and inhibitory postsynaptic currents that can perhaps be attributed to elevated levels of both neurotransmitters.
Because these experiments do not include data on short-term water deprivation (24 hours), no comparison can be made on the Glutamate/GABA decrease seen in our data for the first 24 hours post water deprivation. A similar variation for Glutamate and GABA was found in our data for the Caudate Putamen, which has mostly been associated with the initiation and control of movement related to water consumption, rather than more specifically to the control of thirst 44 .
There are, of course, drawbacks associated with orCEST. First, twice the number of images need to be acquired, which can present practical limitations. Secondly, orCEST (and the majority of the CEST applications for that matter) relies on a stable pH, which should be taken into account in models where pH changes are expected. Changes in pH are responsible for the phenomenon of intermediateto-fast-exchange (k ≥ Δω)-mediated chemical shift averaging 2 , which ultimately results in a frequency shift in the CEST asymmetry curve. While this effect has been taken advantage of in the past 8,9,45-47 , considering the reliance of orCEST on the subtraction of specific frequencies, it is certainly important to consider it in order to choose a suitable model to investigate. Other factors, such as temperature and concentration can also affect the exchangeable resonances, albeit to smaller consequence.
Finally, just as in CEST, asymmetric magnetization transfer (MT) effects may contaminate orCEST signals because of potential magnetization exchange between water molecules bound to larger macromolecules in solid or semisolid phases and free water.
In conclusion, orCEST significantly enhances the specificity in CEST experiments. Our application for Glu and GABA opens an array of possibilities for studies on the inhibitory gabaergic system, while also increasing the specificity for Glutamate imaging using MRI, in a non-invasive manner. These augur well for future molecular imaging studies. ). An M0 image (identical sequence but with zero power on the saturation pulses) for normalization was also acquired.
Materials and Methods

Phantoms
In Vivo
Long-Evans male rats (6-9 weeks old and weighing 220-320g), housed 2 per cage and allowed ad libitum access to food and water before the study started were randomly split into three groups, Control (n=16), 24H Water Deprived (24H, n=16), and 36H Water Deprived (36H, n=16). The first group was allowed ad libitum access to food and water, while the second and third were water deprived for 24h and 36h, respectively. In the beginning of water deprivation, healthy animals were weighted and the water bottles on the cages were made unavailable. All animals were monitored every 12 hours and the continuation of water restriction was decided according to welfare and health of individuals.
Animals were anesthetized with 5% isofluorane for induction, and ~2.5% for maintenance delivered through a nosecone and carried by 95% Oxygen (medical air). Once anesthetized, the animals were placed in a dedicated animal bed and inserted vertically to the MRI scanner. Breathing rate and temperature were monitored throughout the experiment using a SA Instruments Model A total of three slices were acquired across an axial plane at bregma 0.7/-0.9 /-1.46mm. B0 and B1 profiles were optimized per slice prior to each acquisition. Besides the CEST data acquired at multiple , data for B1 and B0 correction was also acquired. One-way ANOVA corrected for multiple comparisons was used to analyse the acquired data.
orCEST Quantification
CEST contrast is determined through the collection of a Z-spectrum, a plot of the normalized z magnetization of water, as described by
where Msat(ω) and M0 represents magnetization saturated at frequency ω and unsaturated magnetization, respectively.
For conventional CEST applications, each metabolite can be characterised by its own CEST asymmetry spectrum,
where i represents the i th metabolite. Such CESTasym spectra tend to exhibit local maxima; if the peak arises from a single metabolite, its saturation at , should provide specificity to metabolite i. However, if another metabolite j has overlapping CESTasym signals, saturation at , would inherently lead to contamination from metabolite j.
One potential solution for this contamination, is to use a kind of "spectral editing": that is, find a way to subtract out one of the metabolite signals. Due to the peaked shape of the spectra, there should exist at least two frequencies for which CESTasym intensities are identical
where ≠ (Fig. 1B) Each frequency pair can thus serve as subtraction points, for which signals from one specific metabolite will be nulled; that is, one can null the effects of metabolite i while preserving contrast from metabolite j (Fig. 1B) . The task for such overlap-resolved CEST (orCEST) spectra is then to select frequency pairs such that contribution from unwanted sources is minimized, while preserving the maximum possible CEST effect for the desired metabolite. For peak signals i,j and nulling frequencies and nulling signal j and and nulling signal i (Fig. 1B) :
Metabolites i and j have thus been resolved with considerably more specificity.
Data Analysis
Image processing and data analysis were done in MATLAB r2015b® (The Mathworks, Nattick, MA, USA), using custom-written code. Intermediate frequency CEST-weighted images were interpolated with spline fitting to obtain the signal intensity S at the desired offsets ωdesired,
To correct for spatial B0 field variations, WASSR correction 49 
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